AI assistant
Sending…
QUEST DIAGNOSTICS INC — Director's Dealing 2026
Feb 20, 2026
30275_dirs_2026-02-20_ffcdcf6c-2975-4cbb-9df7-f4ae2a7a33be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
Period of Report: 2026-02-18
Reporting Person: Plewman Patrick (SVP for Diagnostic Services)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | Common Stock | A | 1952 | — | Acquired | 17333 | Direct |
| 2026-02-18 | Common Stock | F | 244 | $210.01 | Disposed | 17089 | Direct |
| 2026-02-18 | Common Stock | F | 293 | $206.99 | Disposed | 16796 | Direct |
| 2026-02-19 | Common Stock | S | 958 | $204.83 | Disposed | 15838 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Non-Qualifed Stock Option (right to buy) | $204.96 | A | 9009 | Acquired | 2036-02-18 | Common Stock (9009) | Direct |
Footnotes
F1: Represents an award of restricted stock units.
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
F3: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F4: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
More from QUEST DIAGNOSTICS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20